EP4539687A4 - Compositions et leurs utilisations - Google Patents

Compositions et leurs utilisations

Info

Publication number
EP4539687A4
EP4539687A4 EP23822959.5A EP23822959A EP4539687A4 EP 4539687 A4 EP4539687 A4 EP 4539687A4 EP 23822959 A EP23822959 A EP 23822959A EP 4539687 A4 EP4539687 A4 EP 4539687A4
Authority
EP
European Patent Office
Prior art keywords
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP23822959.5A
Other languages
German (de)
English (en)
Other versions
EP4539687A1 (fr
Inventor
Gregg Ward
Mengjin Liu
Yi Jin
Jinhui Hu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutricia Early Life Nutrition Shanghai Co Ltd
Original Assignee
Nutricia Early Life Nutrition Shanghai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia Early Life Nutrition Shanghai Co Ltd filed Critical Nutricia Early Life Nutrition Shanghai Co Ltd
Publication of EP4539687A1 publication Critical patent/EP4539687A1/fr
Publication of EP4539687A4 publication Critical patent/EP4539687A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Anesthesiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
EP23822959.5A 2022-06-16 2023-06-05 Compositions et leurs utilisations Pending EP4539687A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2022099108 2022-06-16
PCT/CN2023/098264 WO2023241390A1 (fr) 2022-06-16 2023-06-05 Compositions et leurs utilisations

Publications (2)

Publication Number Publication Date
EP4539687A1 EP4539687A1 (fr) 2025-04-23
EP4539687A4 true EP4539687A4 (fr) 2026-02-25

Family

ID=89192112

Family Applications (1)

Application Number Title Priority Date Filing Date
EP23822959.5A Pending EP4539687A4 (fr) 2022-06-16 2023-06-05 Compositions et leurs utilisations

Country Status (5)

Country Link
EP (1) EP4539687A4 (fr)
JP (1) JP2025520453A (fr)
CN (1) CN119584873A (fr)
AU (1) AU2023293647A1 (fr)
WO (1) WO2023241390A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119931882B (zh) * 2025-01-23 2025-10-28 广州百芮医疗科技有限公司 一种提升睡眠质量的乳酸菌菌株组合物及应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014221272A1 (en) * 2008-11-03 2014-09-25 Société des Produits Nestlé S.A. A nutritional composition comprising probiotics and improving sleep patterns

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO430496A0 (en) * 1996-12-19 1997-01-23 Arnott's Biscuits Limited Prebiotics and probiotics
AU2006235307B2 (en) * 2005-04-08 2011-07-14 Alimentary Health Ltd Methods of use of orally administered probiotic Bifidobacteria for human beauty benefits
CN101095698B (zh) * 2006-06-26 2010-12-01 青岛东海药业有限公司 酪酸梭菌防治便臭毒素引起的相关症状和疾病的用途
CN106860483A (zh) * 2017-01-06 2017-06-20 家家乐购（北京）科技有限公司 含有双歧杆菌和嗜酸乳杆菌的益生菌复合组合物及应用
CN108244655A (zh) * 2018-02-02 2018-07-06 云南中京国建投资有限公司 一种安神、抗抑郁的合生元组合物及其制剂与应用
CN108671135B (zh) * 2018-08-01 2021-06-08 山东神农医院管理有限公司 一种调理失眠和抑郁的中药益生菌复合物
CN110051003A (zh) * 2019-04-24 2019-07-26 广州能靓生物技术有限公司 一种复合益生菌组合物及其应用

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014221272A1 (en) * 2008-11-03 2014-09-25 Société des Produits Nestlé S.A. A nutritional composition comprising probiotics and improving sleep patterns

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MONTAGNA LORENZA ET AL: "Evaluation of the effects of a probiotic supplementation with respect to placebo on intestinal microflora and secretory IgA production, during antibiotic therapy, in children affected by recurrent airway infections and skin symptoms", 1 March 2014 (2014-03-01), pages 117 - 124, XP093329463, Retrieved from the Internet <URL:https://pubmed.ncbi.nlm.nih.gov/24750797/> *
See also references of WO2023241390A1 *

Also Published As

Publication number Publication date
JP2025520453A (ja) 2025-07-03
WO2023241390A1 (fr) 2023-12-21
EP4539687A1 (fr) 2025-04-23
CN119584873A (zh) 2025-03-07
AU2023293647A1 (en) 2025-01-23

Similar Documents

Publication Publication Date Title
EP4499068A4 (fr) Agents de dégradation d&#39;irak et leurs utilisations
EP4463166A4 (fr) Agents de dégradation d&#39;irak4 et leurs utilisations
EP4489738A4 (fr) Composés hétérocycliques et leurs utilisations
EP4399309A4 (fr) Compositions et procédés de modulation de serpina
EP4393937A4 (fr) Composé stéroïde et conjugué de celui-ci
EP4499149A4 (fr) Agents de dégradation de protéines et leurs utilisations
EP4106870A4 (fr) Compositions et utilisations thérapeutiques de cannabidiol
EP4090332C0 (fr) Compositions de pyrazolopyrimidines substituées et leurs utilisations
EP4064862A4 (fr) Compositions bactériennes et leurs utilisations
EP4204391A4 (fr) Composés lipidiques et compositions de nanoparticules lipidiques
EP4208528C0 (fr) Compositions à forte teneur en huile oléique et leurs utilisations
EP4367198A4 (fr) Compositions géopolymères et procédés
EP4303212C0 (fr) Cristal eutectique d&#39;hydroxytyrosol-nicotinamide, son procédé de préparation et composition associée
EP4456892A4 (fr) Inhibiteurs bicycliques de nicotinamide n-méthyltransférase, compositions et utilisations associées
EP4463173A4 (fr) Compositions postbiotiques et méthodes
PL4179053T3 (pl) Kompozycje i ich zastosowania
EP4539687A4 (fr) Compositions et leurs utilisations
EP4463469A4 (fr) Compositions de cytokine conçues et procédés d&#39;utilisation
IL317275A (en) Collagen compositions and methods of use thereof
EP4021184A4 (fr) Compositions d&#39;amorçage de plante et leurs procédés d&#39;utilisation
EP4444274A4 (fr) Compositions comprenant des phospholipides modifiés et leurs utilisations
IL311867A (en) Trem compositions and methods of use
EP4408966A4 (fr) Compositions de parfum et utilisations de celles-ci
EP4408853A4 (fr) Inhibiteurs de lpxc et leurs utilisations
EP4329806A4 (fr) Compositions anti-siglec et utilisations associées

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20241219

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A23L0033135000

Ipc: A61K0035747000

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40125322

Country of ref document: HK

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 35/747 20150101AFI20251103BHEP

Ipc: A23L 33/135 20160101ALI20251103BHEP

Ipc: A61K 35/745 20150101ALI20251103BHEP

Ipc: A23L 33/125 20160101ALI20251103BHEP

Ipc: A61K 31/7016 20060101ALI20251103BHEP

Ipc: A61P 25/20 20060101ALI20251103BHEP

Ipc: A61P 1/02 20060101ALI20251103BHEP

Ipc: A61Q 19/00 20060101ALI20251103BHEP

Ipc: A61P 17/00 20060101ALI20251103BHEP

Ipc: A61K 31/733 20060101ALI20251103BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20260128

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 35/747 20150101AFI20260122BHEP

Ipc: A23L 33/135 20160101ALI20260122BHEP

Ipc: A61K 35/745 20150101ALI20260122BHEP

Ipc: A23L 33/125 20160101ALI20260122BHEP

Ipc: A61K 31/7016 20060101ALI20260122BHEP

Ipc: A61P 25/20 20060101ALI20260122BHEP

Ipc: A61P 1/02 20060101ALI20260122BHEP

Ipc: A61Q 19/00 20060101ALI20260122BHEP

Ipc: A61P 17/00 20060101ALI20260122BHEP

Ipc: A61K 31/733 20060101ALI20260122BHEP